A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study

Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

(2015) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review

(2013) Suzanne Parker et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients

(2012) Nadezda Petejova et al.   JOURNAL OF CHEMOTHERAPY

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration

(2012) Deirdre M D’Arcy et al.   BMC Pharmacology & Toxicology

Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity

(2011) Ricardo Gálvez et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy

(2011) Fabio Silvio Taccone et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients

(2011) Argyris S Michalopoulos et al.   Annals of Intensive Care

Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa

(2010) B. Layeux et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*

(2010) Anand Kumar et al.   CRITICAL CARE MEDICINE

Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

(2009) Joshua D. Hartzell et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic issues for antibiotics in the critically ill patient

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit*

(2009) Andrew F. Shorr   CRITICAL CARE MEDICINE

Prospects for the next anti-Pseudomonas drug

(2009) Malcolm GP Page et al.   CURRENT OPINION IN PHARMACOLOGY

Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Suboptimal Aminoglycoside Dosing in Critically Ill Patients

(2008) Rhonda S Rea et al.   THERAPEUTIC DRUG MONITORING